Tech Company Financing Transactions
Fluidigm Funding Round
Fluidigm secured a $37 million Series E funding round on 1/8/2007. Investors included EPIC Ventures.
Transaction Overview
Company Name
Announced On
1/8/2007
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$37,000,000
Round
Series E
Investors
EPIC Ventures (Jeffrey Cardon)
Proceeds Purpose
Fluidigm will use the capital to boost sales and marketing of its BioMark system and TOPAZ® system for protein crystallization and to develop new products in the pipeline.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
7000 Shoreline Ct. 100
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Fluidigm creates and manufactures innovative technologies and life-science tools designed to revolutionize biology through ongoing pursuit of scientific truth.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Linthwaite
Chief Financial Officer
Vikram Jog
VP - Bus. Development
Colin McCracken
VP - General Counsel
Nick Khadder
VP - Human Resources
Angela Peters
VP - Operations
Brad Kreger
Browse more venture capital transactions:
Prev: 1/8/2007: Proprius Pharmaceuticals venture capital transaction
Next: 1/9/2007: C-nario venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs